Covered recipient · General Payments record
ZEINA TAKIEDDINE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$953.33
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $443.56 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $243.82 | 14 |
| PFIZER INC. | $69.45 | 3 |
| Lilly USA, LLC | $30.70 | 2 |
| Exact Sciences Corporation | $29.24 | 2 |
| Merck Sharp & Dohme Corporation | $19.80 | 1 |
| Amgen Inc. | $18.23 | 1 |
| Acerta Pharma LLC | $17.78 | 1 |
| ABBVIE INC. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.54 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106196028 | CMS |
| Amgen Inc. | $18.23 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116167960 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.78 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104413561 | CMS |
| Exact Sciences Corporation | $15.79 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114927172 | CMS |
| Exact Sciences Corporation | $13.45 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114927176 | CMS |
| Lilly USA, LLC | $16.29 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135521153 | CMS |
| Lilly USA, LLC | $14.41 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135491046 | CMS |
| Merck Sharp & Dohme LLC | $19.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141633439 | CMS |
| Novo Nordisk Inc | $21.68 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097059132 | CMS |
| Novo Nordisk Inc | $19.80 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097054732 | CMS |
| Novo Nordisk Inc | $16.38 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097009038 | CMS |
| Novo Nordisk Inc | $8.18 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096965897 | CMS |
| Novo Nordisk Inc | $19.31 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096730152 | CMS |
| Novo Nordisk Inc | $8.52 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097182439 | CMS |
| Novo Nordisk Inc | $23.22 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887118 | CMS |
| Novo Nordisk Inc | $18.37 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097263905 | CMS |
| Novo Nordisk Inc | $16.38 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097732227 | CMS |
| Novo Nordisk Inc | $23.20 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096623130 | CMS |
| Novo Nordisk Inc | $5.69 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096806376 | CMS |
| Novo Nordisk Inc | $26.98 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097387987 | CMS |
| Novo Nordisk Inc | $12.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929668 | CMS |
| Novo Nordisk Inc | $23.66 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097431154 | CMS |
| PFIZER INC. | $26.42 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131055484 | CMS |
| PFIZER INC. | $24.42 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131213994 | CMS |
| PFIZER INC. | $18.61 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131939385 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.